Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avalon GloboCare (ALBT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Avalon GloboCare (ALBT) over the last 10 years, with Q3 2025 value amounting to $4.1 million.

  • Avalon GloboCare's Shares Outstanding (Weighted Average) rose 34019.52% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 34019.52%. This contributed to the annual value of $936614.0 for FY2024, which is 3343.37% up from last year.
  • Per Avalon GloboCare's latest filing, its Shares Outstanding (Weighted Average) stood at $4.1 million for Q3 2025, which was up 34019.52% from $2.2 million recorded in Q2 2025.
  • Avalon GloboCare's Shares Outstanding (Weighted Average)'s 5-year high stood at $85.4 million during Q3 2021, with a 5-year trough of $701932.0 in Q4 2023.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $17.5 million, with a median of $8.5 million in 2021.
  • In the last 5 years, Avalon GloboCare's Shares Outstanding (Weighted Average) tumbled by 9270.16% in 2024 and then surged by 34019.52% in 2025.
  • Quarter analysis of 5 years shows Avalon GloboCare's Shares Outstanding (Weighted Average) stood at $8.5 million in 2021, then grew by 9.86% to $9.3 million in 2022, then tumbled by 92.48% to $701932.0 in 2023, then skyrocketed by 33.43% to $936614.0 in 2024, then soared by 334.47% to $4.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $4.1 million in Q3 2025, compared to $2.2 million in Q2 2025 and $1.6 million in Q1 2025.